Medicaid Pressure And Biotech Shifts
Kilder
- STAT: STAT+: How Trump’s funding cuts are reshaping the health system
- STAT: How Trump’s cuts are reshaping America’s health system - STAT
- STAT: CDC releases latest life expectancy data - STAT
- STAT: STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
- Endpoints: OmicsBank raises $2.25M to bring overseas patient data to biopharma
- Endpoints: ARCH and Population Health join China blitz with Haisco deal
- Endpoints: Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg
- Reuters: Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
- Seeking Alpha: Bristol Myers Squibb exits Cellares pact (BMY:NYSE) - Seeking Alpha
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.